Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences net income (loss) attributable to Gilead ($M) ($M)
Form 10-Q / 10-K (DB)
Latest, FY2025
8,510
Period ended Dec 31, 2025
Change on a year earlier
+1,672.9%
480 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net income (loss) attributable to Gilead ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8,510 | +1,672.9% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 480 | -91.5% | Form 10-K (filed 2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 5,665 | +23.4% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 4,592 | -26.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 6,225 | +4,961.0% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 123 | -97.7% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 5,386 | -1.3% | Form 10-K (filed 2020-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 5,455 | +17.9% | Form 10-K (filed 2019-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 4,628 | -65.7% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 13,501 | -25.4% | Form 10-K (filed 2017-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 18,108 | +49.6% | Form 10-K (filed 2016-02-24) ↗ |
| FY2014 | Dec 31, 2014 | 12,101 | +293.5% | Form 10-K (filed 2015-02-25) ↗ |
| FY2013 | Dec 31, 2013 | 3,075 | +18.6% | Form 10-K (filed 2015-02-25) ↗ |
| FY2012 | Dec 31, 2012 | 2,592 | -7.5% | Form 10-K (filed 2015-02-25) ↗ |
| FY2011 | Dec 31, 2011 | 2,804 | -3.4% | Form 10-K (filed 2012-02-23) ↗ |
| FY2010 | Dec 31, 2010 | 2,901 | +10.1% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 2,636 | +33.2% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 1,979 | +24.9% | Form 10-K (filed 2010-03-01) ↗ |
| FY2007 | Dec 31, 2007 | 1,585 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Net income (loss) attributable to Gilead ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_netinc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.